These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9527801

  • 21. Serotyping of quinolone-resistant Neisseria gonorrhoeae isolates with alterations in GyrA and ParC.
    Deguchi T, Yasuda M, Maeda SI, Saito I, Kawada Y.
    J Antimicrob Chemother; 1998 Mar; 41(3):418-20. PubMed ID: 9578173
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Klebsiella pneumoniae and Enterobacter cloacae with fluoroquinolone resistance-associated amino acid alterations in GyrA and ParC.
    Deguchi T, Yasuda M, Kawamura T, Takahashi Y, Okezaki E, Nagata O, Kato H, Kawada Y.
    J Antimicrob Chemother; 1997 Dec; 40(6):907-9. PubMed ID: 9462448
    [No Abstract] [Full Text] [Related]

  • 28. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
    Jalal S, Wretlind B.
    Microb Drug Resist; 1998 Dec; 4(4):257-61. PubMed ID: 9988043
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Analysis of regions determining resistence to fluoroquinolones in genes gyrA and parC in clinical isolates of Mycoplasma hominis].
    Gushchin AE, Ladygina VG, Govorun VM, Taraskina AM, Savicheva AM.
    Mol Gen Mikrobiol Virusol; 2000 Dec; (4):33-5. PubMed ID: 11186458
    [Abstract] [Full Text] [Related]

  • 32. In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis.
    Tankovic J, Bachoual R, Ouabdesselam S, Boudjadja A, Soussy CJ.
    J Antimicrob Chemother; 1999 May; 43 Suppl B():19-23. PubMed ID: 10382871
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
    Shultz TR, Tapsall JW, White PA.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.
    Valdezate S, Vindel A, Echeita A, Baquero F, Cantó R.
    Antimicrob Agents Chemother; 2002 Mar; 46(3):665-71. PubMed ID: 11850246
    [Abstract] [Full Text] [Related]

  • 39. Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained In vitro.
    Dessus-Babus S, Bébéar CM, Charron A, Bébéar C, de Barbeyrac B.
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2474-81. PubMed ID: 9756744
    [Abstract] [Full Text] [Related]

  • 40. A mutation in QRDR in the ParC subunit of topoisomerase IV was responsible for fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
    Choi H, Lee HJ, Lee Y.
    Yonsei Med J; 1998 Dec; 39(6):541-5. PubMed ID: 10097681
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.